Cellectis announced that Steve Doares, Ph.D., joins Cellectis from Biogen as Senior Vice President of US Manufacturing Manufacturing and Site Head of Raleigh manufacturing plant in NC. Dr. Doares is responsible for the deployment of Cellectis' proprietary gene-editing cell manufacturing plant in Raleigh, NC, for clinical and commercial supplies of the Company’s current immuno-oncology UCART product candidates. Steve Doares joins Cellectis from Biogen where he was VP, Global Manufacturing Sciences, responsible for technology transfer into GMP manufacturing of processes from clinical through commercialization stages for Biogen’s therapeutic product portfolio, both internally and externally. In his previous role, he provided scientific expertise for process troubleshooting and lifecycle improvements; process monitoring, advanced modeling, and PAT implementation; and technical and vendor management expertise for raw materials and SUS/disposables. Steve was also overseeing both drug substance/API and drug product processes, for biologics and pharmaceuticals, and was with Biogen since 2010.